1Sitruk-Ware R.Pharmacological profile of progestins[J].Maturitas,2004,47(4):277-283.
2Mandelin E,Koistinen R.Levonogestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle:another contraceptive mechanism[J].Hum Reprod,1997,12(24):2671-2726.
3Ortiz ME,Croxatto HB.The mode of action of IUDs[J].Contraception,1987,36(1):37-53.
4Kkainen T,Allonen H,Haukkammaa M,et al.Effective contraception with the levonorgestrel-releasing intrauterine device:12-month report of a European multicenterstudy[J].Contraception,1987,36 (2):169-179.
5Andersson K,Odlind V.Levonogestrel-releasing and copper IUDs during five years:a randomized comparative trial[J].Contraception,1994,49(1):56-72.
6Backman T,Rauramo I,Huhtala S,et al.Pregnancy during the use of levonorgestrel releasing intrauterine system[J].Obstet Gynecol,2004,190(1):50-54.
7Savage UK,Masters SJ,Smid MC,et al.Hysteroscopic sterilization in a large group practice:experience and effectiveness[J].Obstet Gynecol,2009,114(6):1227-1231.
8Backman T.Benefit risk assessment of the levonorgestrel intrauter-ine system in contraception[J].Drug Saf,2004,27(15):1185-1204.
9Nilsson CG,Haukkamaa M,Vierola H,et al.Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD[J].Clin Endocrinol,1982,17(6):529-536.
10Ndersson K,Batar I,Rybo G.Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T[J].Cotraception,1992,46(5):575-584.
10Muneyyirci-Delale O, Gupta A, Abraham C, et al. Management of dysfunc- tional uterine bleeding based on endometrial thickness[J]. Int J Womens Health, 201 O, 2 ( 3 ) : 297 -302.
